Skip to content
Home/Companies/MedTech/INBRACE

INBRACE

MedTech·US·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns INBRACE?

INBRACE is currently owned by Novo Holdings through Novo Holdings Growth Investments (1999 vintage), since 2022.

Hand-verified · updated 2026-08-18

Novo Holdings
Investor
Novo Holdings
Novo Holdings Growth Investments · 1999 · Growth

Key facts

HQUnited States
SectorMedTech
StatusActive

More from Novo Holdings Growth Investments

Other portfolio companies in the same fund.

Surya Hospitals
Active
HealthcareIndia· 2026
Phasecraft
Phasecraft
Active
Deep TechUK· 2025
AvenCell
Active
BiotechUS· 2024
Cleveland Diagnostics
Active
MedTechUS· 2024
Convergent
Active
BiotechUS· 2024
Medi Assist
Active
HealthTechIndia· 2024

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Amedes Group
Active
General AtlanticGermany
Appasamy
Appasamy
Active
Warburg PincusIndia
Biocomposites
Biocomposites
Active
TA AssociatesUS
Track Inbrace

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Inbrace?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Inbrace.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue